esmolol has been researched along with Disease Models, Animal in 42 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (4.76) | 18.7374 |
| 1990's | 3 (7.14) | 18.2507 |
| 2000's | 15 (35.71) | 29.6817 |
| 2010's | 15 (35.71) | 24.3611 |
| 2020's | 7 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| An, H; Guo, CA; Liu, HB; Ma, L; Su, XL; Wang, YZ; Zhang, B; Zhen, LL | 1 |
| Beyer, CA; Caples, CM; Gilbert, Z; Grayson, JK; Hoareau, GL; Johnson, MA; Neff, LP; Spruce, MW; Williams, TK | 1 |
| Cho, WS; Jung, YS; Kang, MW; Kim, KS; Kim, T; Kwon, WY; Lee, B; Lee, JC; Lee, MS; Shin, SM; Suh, GJ | 1 |
| Affatato, R; Babini, G; Belloli, A; Boccardo, A; Cucino, A; De Giorgio, D; Fumagalli, F; Latini, R; Magliocca, A; Minoli, L; Nespoli, F; Novelli, D; Olivari, D; Pravettoni, D; Ristagno, G; Romanelli, P; Ruggeri, L; Scanziani, E; Staszewsky, L; Zani, D | 1 |
| Dong, S; He, X; Lu, Y; Wang, D; Wang, W; Yang, Y; Zhang, P | 1 |
| Creteur, J; Herpain, A; Hosokawa, K; Pereira, AJ; Post, EH; Su, F; Taccone, FS; Vincent, JL | 1 |
| Du, W; Liu, D; Long, Y; Wang, X | 1 |
| Chang, YT; Cheng, CC; Huang, MS; Huang, NC; Huang, WC; Hung, YM; Ke, MW; Tsai, JS; Wann, SR | 1 |
| Aass, T; Chambers, DJ; Dahle, GO; Grong, K; Haaverstad, R; Matre, K; Moen, CA; Nesheim, K; Solholm, A; Stangeland, L; Urban, M | 1 |
| Abubakra, S; Garutti, I; Huerta, L; Ortega, J; Paredes, SD; Ramos, S; Rancan, L; Simón, C; Vara, E | 1 |
| Chen, Y; Cheng, Y; Chu, L; Duan, R; Li, H; Li, J; Xia, D; Yuan, J; Zhang, J; Zhang, Y; Zhao, S; Zhao, X | 1 |
| Fan, Y; Hepler, E; Huang, H; Liu, Y; Male, S; Mao, J; Po, SS; Scherlag, BJ; Varma, V; Xia, W | 1 |
| Friese, RS; Gomez, CT; Ibrahim-Zada, I; Rhee, P; Weller, J | 1 |
| Al Kattani, N; Delemazure, J; Dessales, N; Issa, K; Kimmoun, A; Levy, B; Louis, H; Marie, PY; Wei, C | 1 |
| Allaouchiche, B; Ayoub, JY; Bonnet, JM; Dauwalder, O; Etienne, J; Jacquet-Lagrèze, M; Junot, S; Paquet, C; Restagno, D; Vandenesch, F | 1 |
| Liu, LJ; Lu, J; Qian, HY; Shen, Y; Zhu, CL | 1 |
| Guo, Z; Meng, XX; Xie, LS; Yang, JH | 1 |
| Kim, HK; Pinsky, MR | 1 |
| Guo, JH; Jackman, WM; Jiang, H; Lazzara, R; Lin, J; Lu, Z; Niu, G; Po, SS; Scherlag, BJ; Yu, L | 1 |
| Dongdong, Z; Guosheng, L; Jingjun, L; Mingwei, B; Yan, Z | 1 |
| Goyagi, T; Horiguchi, T; Nishikawa, T; Tobe, Y | 1 |
| Rudiger, A | 1 |
| Fujise, K; Huang, MH; McConnell, BK; Nguyen, V; Poh, KK; Rastogi, S; Tan, HC; Uretsky, BF; Wijaya, C; Wu, Y | 1 |
| Aboab, J; Annane, D; Gharbi, M; Jourdain, M; Mangalaboyi, J; Mansart, A; Sebille, V | 1 |
| Ishizaka, A; Kotake, Y; Morisaki, H; Serita, R; Suzuki, T; Takeda, J; Yamamoto, M | 1 |
| Bijnens, B; Broscheit, JA; Claus, P; Ertl, G; Strotmann, JM; Sutherland, GR; Voelker, W; Weidemann, F | 1 |
| Pinsky, MR; Strum, DP | 1 |
| Anetseder, M; Broscheit, JA; Greim, CA; Kessler, M; Rinck, A; Roewer, N | 1 |
| Akhter, SA; Bulcao, CF; Duffy, JY; Lyons, JM; McLean, KM; Pandalai, PK; Pearl, JM; Wagner, CJ | 1 |
| Kirby, DS; Lobato, EB; Muehlschlegel, JD; Sidi, A | 1 |
| Akhter, SA; Bulcao, CF; D'Souza, KM; Duffy, JY; McLean, KM; Merrill, WH; Pandalai, PK; Pearl, JM | 1 |
| Fusilli, L; Lee, W; Patel, J; Regan, TJ | 1 |
| Guerrero, JL; Levangie, MW; Picard, MH; Weissman, NJ; Weyman, AE | 1 |
| Mehlhorn, U | 1 |
| Allen, SJ; Davis, KL; Geissler, HJ; Hekmat, K; Laine, GA; Mehlhorn, U; Ostrin, EJ; Warters, RD | 1 |
| Gaasch, WH; John, RM; Martin, DT; Peralta, AO; Taggart, PI; Venditti, FJ | 1 |
| Liachenko, S; Tang, P; Xu, Y | 1 |
| Hou, Y; Jackman, WM; Lazzara, R; Schauerte, P; Scherlag, BJ; Scherlag, M; Sun, YX; Yamanashi, WS | 1 |
| Davis, RF; Sidi, A | 1 |
| Antman, EM; Braunwald, E; Kirshenbaum, J; Kloner, RA; Lange, R | 1 |
3 review(s) available for esmolol and Disease Models, Animal
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosphate; Adsorption; Adult; Africa, Eastern; Aged; Air Pollutants; Air Pollution; Air Pollution, Indoor; Alcohol Drinking; Allergens; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Antibodies; Antibodies, Immobilized; Antigen Presentation; Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Aptamers, Nucleotide; Asthma; Asthma, Exercise-Induced; Atrophy; Autophagy; Azoospermia; Bacillus cereus; Bacterial Infections; Beclin-1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biofouling; Biological Monitoring; Biomarkers; Biomarkers, Tumor; Biosensing Techniques; Blastocyst; Bone Neoplasms; Bone Regeneration; Bronchoconstriction; Burkitt Lymphoma; C9orf72 Protein; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Cardiomyopathies; Caregivers; Carmine; Case-Control Studies; Catalysis; Cattle; Cause of Death; CCAAT-Enhancer-Binding Protein-alpha; CD8-Positive T-Lymphocytes; Cefepime; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Transdifferentiation; Chelating Agents; Chemical and Drug Induced Liver Injury, Chronic; Chemoradiotherapy, Adjuvant; Child; Child, Preschool; China; Chlorquinaldol; Cholangiocarcinoma; Cholera; Chromatin; Clinical Trials as Topic; Cognitive Dysfunction; Cohort Studies; Colonic Neoplasms; Colorectal Neoplasms; Colorimetry; Cooking; Coordination Complexes; COVID-19; Creatinine; CRISPR-Cas Systems; Critical Care; Critical Illness; Cross-Sectional Studies; Cryopreservation; Cryoprotective Agents; Cysteine; Cytokines; Device Removal; Diet; Diet, High-Fat; Diet, Mediterranean; Dietary Supplements; Dimethyl Sulfoxide; Dipeptides; Disease Models, Animal; Dithiothreitol; DNA; DNA Repeat Expansion; DNA, Bacterial; DNA, Complementary; Dopamine; Electrochemical Techniques; Electrodes; Endocannabinoids; Environmental Exposure; Environmental Monitoring; Environmental Pollutants; Enzyme-Linked Immunosorbent Assay; Erlotinib Hydrochloride; Escherichia coli; Escherichia coli O157; Esophageal Neoplasms; Esophagitis, Peptic; Ethylene Glycol; Europium; Exanthema; Fallopian Tubes; Feces; Female; Fertilization in Vitro; Fluoresceins; Fluorescent Dyes; Follicle Stimulating Hormone; Follow-Up Studies; Food Microbiology; Forced Expiratory Volume; Forkhead Transcription Factors; Frontotemporal Dementia; G-Quadruplexes; Galactose; Gastroenteritis; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gastrointestinal Neoplasms; Gastrointestinal Tract; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genital Neoplasms, Female; Genome-Wide Association Study; Genome, Viral; Genomics; Genotype; Glucose; Glutathione; Glycerol; Gold; Graphite; GTPase-Activating Proteins; Heat-Shock Proteins; Heme Oxygenase-1; Hepacivirus; Hepatitis C; Hepatocytes; Histamine; Histocompatibility Antigens Class II; Hoarseness; Hospice and Palliative Care Nursing; Humans; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydroxybenzoates; Hydroxyl Radical; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperthermia, Induced; Hysteroscopy; Immunoassay; Indigo Carmine; Inflammation; Inflammatory Bowel Diseases; Insulin Resistance; Intensive Care Units; Interleukin-11; Interleukin-6; Interleukins; Iodine Radioisotopes; Iran; Iridium; Islets of Langerhans; Kinetics; Lactation; Lactobacillus; Lactobacillus plantarum; Lamins; Latin America; Lead; Lectins; Leukopenia; Ligands; Limit of Detection; Lipopolysaccharides; Lipoprotein Lipase; Liver; Liver Cirrhosis; Liver Neoplasms; Lolium; Luminescent Measurements; Luminol; Lung; Luteinizing Hormone; Macrophages; Magnetic Phenomena; Magnetic Resonance Imaging; Male; Malnutrition; Maltose; Manganese Compounds; Maternal Nutritional Physiological Phenomena; Melatonin; Metabolic Engineering; Metal Nanoparticles; Metallocenes; Metaplasia; Methicillin-Resistant Staphylococcus aureus; Methylation; Mevalonic Acid; Mexico; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbial Sensitivity Tests; Microbiota; MicroRNAs; Milk; Mitomycin; Molecular Diagnostic Techniques; Molecular Docking Simulation; Monte Carlo Method; Moringa oleifera; Multiple Sclerosis; Muscle Strength; Muscle, Skeletal; Nanocomposites; Nanotubes, Carbon; Neoadjuvant Therapy; Neoplasms; Neurodegenerative Diseases; Neurotransmitter Agents; NF-E2-Related Factor 2; Nickel; Nitrogen Dioxide; Non-alcoholic Fatty Liver Disease; Nucleic Acid Amplification Techniques; Nucleic Acid Hybridization; Nucleocapsid Proteins; Nutritional Status; Obesity; Osteogenesis; Osteosarcoma; Oxidation-Reduction; Oxides; Oxygen; Oxyquinoline; Pain; Palliative Care; Pancreatic Neoplasms; Pandemics; Particulate Matter; Peroxidase; Peroxidases; Phagocytosis; Phaseolus; Photothermal Therapy; Point-of-Care Systems; Polyethyleneimine; Polymers; Polymorphism, Single Nucleotide; Polysomnography; Postoperative Complications; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Prevalence; Printing, Three-Dimensional; Probability; Probiotics; Prognosis; Prophages; Prospective Studies; Proteomics; Proto-Oncogene Proteins; Pseudomonas aeruginosa; Pseudomonas putida; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Pyridines; Pyrroles; Quality of Life; Quinolones; Rabbits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptors, Histamine; Receptors, Histamine H2; Recombinases; Rectal Neoplasms; Reperfusion Injury; Respiration; Respiratory Function Tests; Respiratory Rate; Respiratory Sounds; Retrospective Studies; rho GTP-Binding Proteins; Risk Assessment; Risk Factors; RNA; RNA, Messenger; RNA, Ribosomal, 16S; Robotic Surgical Procedures; Running; Rural Population; Saccharomyces cerevisiae; Salpingectomy; Sarcopenia; SARS-CoV-2; Seeds; Semen; Sensitivity and Specificity; Sepsis; Shock, Septic; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Skin Neoplasms; Sleep Apnea, Obstructive; Soil; Spain; Spectrum Analysis, Raman; Sperm Retrieval; Spermatozoa; Spirometry; Staphylococcus aureus; STAT3 Transcription Factor; Stereoisomerism; Sterilization, Tubal; Stroke Volume; Sulfadiazine; Sulfites; Superoxide Dismutase; Surface Plasmon Resonance; tau Proteins; Testis; Testosterone; Thioredoxin-Disulfide Reductase; Thyroid Neoplasms; Thyroidectomy; Trans-Activators; Transcription Factor AP-1; Treatment Outcome; Triazoles; Triclosan; Trifluridine; Tumor Microenvironment; Tumor Necrosis Factor-alpha; United States; Uracil; Vagina; Vegetables; Ventricular Function, Left; Ventricular Pressure; Vibrio cholerae; Vietnam; Virulence; Vital Capacity; Vitrification; Walking; Water; Water Pollutants, Radioactive; Whole Genome Sequencing; Wind; YAP-Signaling Proteins; Zeolites; Zinc Oxide | 2023 |
Beta-block the septic heart.
Topics: Adrenergic beta-Antagonists; Animals; Cardiotonic Agents; Disease Models, Animal; Heart; Humans; Propanolamines; Propranolol; Rats; Sepsis; Systemic Inflammatory Response Syndrome | 2010 |
Experimental and clinical observations on the efficacy of esmolol in myocardial ischemia.
Topics: Adrenergic beta-Antagonists; Animals; Arterial Occlusive Diseases; Clinical Trials as Topic; Coronary Disease; Disease Models, Animal; Dogs; Hemodynamics; Humans; Infusions, Parenteral; Myocardial Infarction; Oxygen Consumption; Propanolamines; Syndrome; Time Factors | 1985 |
3 trial(s) available for esmolol and Disease Models, Animal
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosphate; Adsorption; Adult; Africa, Eastern; Aged; Air Pollutants; Air Pollution; Air Pollution, Indoor; Alcohol Drinking; Allergens; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Antibodies; Antibodies, Immobilized; Antigen Presentation; Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Aptamers, Nucleotide; Asthma; Asthma, Exercise-Induced; Atrophy; Autophagy; Azoospermia; Bacillus cereus; Bacterial Infections; Beclin-1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biofouling; Biological Monitoring; Biomarkers; Biomarkers, Tumor; Biosensing Techniques; Blastocyst; Bone Neoplasms; Bone Regeneration; Bronchoconstriction; Burkitt Lymphoma; C9orf72 Protein; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Cardiomyopathies; Caregivers; Carmine; Case-Control Studies; Catalysis; Cattle; Cause of Death; CCAAT-Enhancer-Binding Protein-alpha; CD8-Positive T-Lymphocytes; Cefepime; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Transdifferentiation; Chelating Agents; Chemical and Drug Induced Liver Injury, Chronic; Chemoradiotherapy, Adjuvant; Child; Child, Preschool; China; Chlorquinaldol; Cholangiocarcinoma; Cholera; Chromatin; Clinical Trials as Topic; Cognitive Dysfunction; Cohort Studies; Colonic Neoplasms; Colorectal Neoplasms; Colorimetry; Cooking; Coordination Complexes; COVID-19; Creatinine; CRISPR-Cas Systems; Critical Care; Critical Illness; Cross-Sectional Studies; Cryopreservation; Cryoprotective Agents; Cysteine; Cytokines; Device Removal; Diet; Diet, High-Fat; Diet, Mediterranean; Dietary Supplements; Dimethyl Sulfoxide; Dipeptides; Disease Models, Animal; Dithiothreitol; DNA; DNA Repeat Expansion; DNA, Bacterial; DNA, Complementary; Dopamine; Electrochemical Techniques; Electrodes; Endocannabinoids; Environmental Exposure; Environmental Monitoring; Environmental Pollutants; Enzyme-Linked Immunosorbent Assay; Erlotinib Hydrochloride; Escherichia coli; Escherichia coli O157; Esophageal Neoplasms; Esophagitis, Peptic; Ethylene Glycol; Europium; Exanthema; Fallopian Tubes; Feces; Female; Fertilization in Vitro; Fluoresceins; Fluorescent Dyes; Follicle Stimulating Hormone; Follow-Up Studies; Food Microbiology; Forced Expiratory Volume; Forkhead Transcription Factors; Frontotemporal Dementia; G-Quadruplexes; Galactose; Gastroenteritis; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gastrointestinal Neoplasms; Gastrointestinal Tract; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genital Neoplasms, Female; Genome-Wide Association Study; Genome, Viral; Genomics; Genotype; Glucose; Glutathione; Glycerol; Gold; Graphite; GTPase-Activating Proteins; Heat-Shock Proteins; Heme Oxygenase-1; Hepacivirus; Hepatitis C; Hepatocytes; Histamine; Histocompatibility Antigens Class II; Hoarseness; Hospice and Palliative Care Nursing; Humans; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydroxybenzoates; Hydroxyl Radical; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperthermia, Induced; Hysteroscopy; Immunoassay; Indigo Carmine; Inflammation; Inflammatory Bowel Diseases; Insulin Resistance; Intensive Care Units; Interleukin-11; Interleukin-6; Interleukins; Iodine Radioisotopes; Iran; Iridium; Islets of Langerhans; Kinetics; Lactation; Lactobacillus; Lactobacillus plantarum; Lamins; Latin America; Lead; Lectins; Leukopenia; Ligands; Limit of Detection; Lipopolysaccharides; Lipoprotein Lipase; Liver; Liver Cirrhosis; Liver Neoplasms; Lolium; Luminescent Measurements; Luminol; Lung; Luteinizing Hormone; Macrophages; Magnetic Phenomena; Magnetic Resonance Imaging; Male; Malnutrition; Maltose; Manganese Compounds; Maternal Nutritional Physiological Phenomena; Melatonin; Metabolic Engineering; Metal Nanoparticles; Metallocenes; Metaplasia; Methicillin-Resistant Staphylococcus aureus; Methylation; Mevalonic Acid; Mexico; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbial Sensitivity Tests; Microbiota; MicroRNAs; Milk; Mitomycin; Molecular Diagnostic Techniques; Molecular Docking Simulation; Monte Carlo Method; Moringa oleifera; Multiple Sclerosis; Muscle Strength; Muscle, Skeletal; Nanocomposites; Nanotubes, Carbon; Neoadjuvant Therapy; Neoplasms; Neurodegenerative Diseases; Neurotransmitter Agents; NF-E2-Related Factor 2; Nickel; Nitrogen Dioxide; Non-alcoholic Fatty Liver Disease; Nucleic Acid Amplification Techniques; Nucleic Acid Hybridization; Nucleocapsid Proteins; Nutritional Status; Obesity; Osteogenesis; Osteosarcoma; Oxidation-Reduction; Oxides; Oxygen; Oxyquinoline; Pain; Palliative Care; Pancreatic Neoplasms; Pandemics; Particulate Matter; Peroxidase; Peroxidases; Phagocytosis; Phaseolus; Photothermal Therapy; Point-of-Care Systems; Polyethyleneimine; Polymers; Polymorphism, Single Nucleotide; Polysomnography; Postoperative Complications; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Prevalence; Printing, Three-Dimensional; Probability; Probiotics; Prognosis; Prophages; Prospective Studies; Proteomics; Proto-Oncogene Proteins; Pseudomonas aeruginosa; Pseudomonas putida; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Pyridines; Pyrroles; Quality of Life; Quinolones; Rabbits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptors, Histamine; Receptors, Histamine H2; Recombinases; Rectal Neoplasms; Reperfusion Injury; Respiration; Respiratory Function Tests; Respiratory Rate; Respiratory Sounds; Retrospective Studies; rho GTP-Binding Proteins; Risk Assessment; Risk Factors; RNA; RNA, Messenger; RNA, Ribosomal, 16S; Robotic Surgical Procedures; Running; Rural Population; Saccharomyces cerevisiae; Salpingectomy; Sarcopenia; SARS-CoV-2; Seeds; Semen; Sensitivity and Specificity; Sepsis; Shock, Septic; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Skin Neoplasms; Sleep Apnea, Obstructive; Soil; Spain; Spectrum Analysis, Raman; Sperm Retrieval; Spermatozoa; Spirometry; Staphylococcus aureus; STAT3 Transcription Factor; Stereoisomerism; Sterilization, Tubal; Stroke Volume; Sulfadiazine; Sulfites; Superoxide Dismutase; Surface Plasmon Resonance; tau Proteins; Testis; Testosterone; Thioredoxin-Disulfide Reductase; Thyroid Neoplasms; Thyroidectomy; Trans-Activators; Transcription Factor AP-1; Treatment Outcome; Triazoles; Triclosan; Trifluridine; Tumor Microenvironment; Tumor Necrosis Factor-alpha; United States; Uracil; Vagina; Vegetables; Ventricular Function, Left; Ventricular Pressure; Vibrio cholerae; Vietnam; Virulence; Vital Capacity; Vitrification; Walking; Water; Water Pollutants, Radioactive; Whole Genome Sequencing; Wind; YAP-Signaling Proteins; Zeolites; Zinc Oxide | 2023 |
Improved myocardial protection using continuous coronary perfusion with normothermic blood and beta-blockade with esmolol.
Topics: Adrenergic beta-Antagonists; Animals; Cardioplegic Solutions; Coronary Artery Bypass; Coronary Disease; Disease Models, Animal; Dogs; Edema, Cardiac; Female; Heart Arrest, Induced; Heart-Assist Devices; Humans; Male; Myocardial Reperfusion Injury; Propanolamines; Temperature; Ventricular Function, Left | 1997 |
Experimental and clinical observations on the efficacy of esmolol in myocardial ischemia.
Topics: Adrenergic beta-Antagonists; Animals; Arterial Occlusive Diseases; Clinical Trials as Topic; Coronary Disease; Disease Models, Animal; Dogs; Hemodynamics; Humans; Infusions, Parenteral; Myocardial Infarction; Oxygen Consumption; Propanolamines; Syndrome; Time Factors | 1985 |
38 other study(ies) available for esmolol and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Esmolol inhibits inflammation and apoptosis in the intestinal tissue via the overexpression of NF-κB-p65 in the early stage sepsis rats.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Blotting, Western; Disease Models, Animal; Inflammation; Intestinal Mucosa; Propanolamines; Rats; Sepsis; Survival Analysis; Transcription Factor RelA | 2020 |
Esmolol reduces myocardial injury induced by resuscitative endovascular balloon occlusion of the aorta (REBOA) in a porcine model of hemorrhagic shock.
Topics: Animals; Aorta; Balloon Occlusion; Disease Models, Animal; Endovascular Procedures; Propanolamines; Resuscitation; Shock, Hemorrhagic; Swine | 2020 |
Pulse Oximeter Plethysmograph Variation During Hemorrhage in Beta-Blocker-Treated Swine.
Topics: Animals; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Feasibility Studies; Heart Rate; Humans; Male; Oximetry; Oxygen; Plethysmography; Propanolamines; Shock, Hemorrhagic; Sus scrofa | 2020 |
Esmolol during cardiopulmonary resuscitation reduces neurological injury in a porcine model of cardiac arrest.
Topics: Animals; Blood Gas Analysis; Brain; Cardiopulmonary Resuscitation; Disease Models, Animal; Heart Arrest; Hemodynamics; Male; Nerve Degeneration; Neurons; Perfusion; Phosphopyruvate Hydratase; Pressure; Propanolamines; Swine | 2021 |
Esmolol reduces apoptosis and inflammation in early sepsis rats with abdominal infection.
Topics: Abdomen; Adrenergic beta-1 Receptor Antagonists; Animals; Anti-Bacterial Agents; Apoptosis; bcl-2-Associated X Protein; Disease Models, Animal; HMGB1 Protein; Inflammation Mediators; Interleukin-6; Male; Propanolamines; Proto-Oncogene Proteins c-bcl-2; Rats; Sepsis; Surgical Wound Infection; Tumor Necrosis Factor-alpha | 2017 |
Esmolol Administration to Control Tachycardia in an Ovine Model of Peritonitis.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Disease Models, Animal; Female; Heart Rate; Hemodynamics; Peritonitis; Propanolamines; Prospective Studies; Random Allocation; Sheep; Tachycardia | 2017 |
The β-Blocker Esmolol Restores the Vascular Waterfall Phenomenon After Acute Endotoxemia.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Disease Models, Animal; Dogs; Echocardiography; Endotoxemia; Female; Hemodynamics; Male; Norepinephrine; Propanolamines; Random Allocation; Shock, Septic | 2017 |
Effects of epinephrine on heart rate variability and cytokines in a rat sepsis model.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-1 Receptor Antagonists; Animals; Cytokines; Disease Models, Animal; Epinephrine; Heart Rate; Male; Propanolamines; Propranolol; Rats; Rats, Sprague-Dawley; Sepsis | 2020 |
Left ventricular dysfunction after two hours of polarizing or depolarizing cardioplegic arrest in a porcine model.
Topics: Adenosine; Animals; Cardioplegic Solutions; Cardiopulmonary Bypass; Disease Models, Animal; Heart Arrest, Induced; Magnesium; Potassium; Propanolamines; Swine; Ventricular Dysfunction, Left | 2019 |
Effects of Intraoperative Infusion of Esmolol on Systemic and Pulmonary Inflammation in a Porcine Experimental Model of Lung Resection Surgery.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Anti-Inflammatory Agents; Biomarkers; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Drug Administration Schedule; Inflammation Mediators; Infusions, Intravenous; Interleukin-1; Intraoperative Care; Lung; Pneumonectomy; Pneumonia; Propanolamines; Pulmonary Edema; Sus scrofa; Time Factors; Tumor Necrosis Factor-alpha | 2019 |
Beta-adrenergic activation induces cardiac collapse by aggravating cardiomyocyte contractile dysfunction in bupivacaine intoxication.
Topics: Anesthesia; Animals; Blood Pressure; Bupivacaine; Cardiotoxicity; Chloral Hydrate; Disease Models, Animal; Electrocardiography; Epinephrine; Heart Ventricles; Humans; Isoproterenol; Mice; Myocardial Contraction; Propanolamines; Rats; Reactive Oxygen Species | 2018 |
Experimental model of focal atrial tachycardia: clinical correlates.
Topics: Animals; Atropine; Disease Models, Animal; Dogs; Electric Stimulation; Electrophysiologic Techniques, Cardiac; Epinephrine; Heart Conduction System; Propanolamines; Tachycardia, Supraventricular | 2013 |
Inhibition of sepsis-induced inflammatory response by β1-adrenergic antagonists.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; BRCA1 Protein; Disease Models, Animal; Gene Expression Regulation; Kaplan-Meier Estimate; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Microarray Analysis; Molecular Biology; NF-kappa B p50 Subunit; Propanolamines; Random Allocation; Real-Time Polymerase Chain Reaction; Reference Values; RNA; Sepsis; Survival Analysis; Systemic Inflammatory Response Syndrome | 2014 |
β1-Adrenergic Inhibition Improves Cardiac and Vascular Function in Experimental Septic Shock.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Disease Models, Animal; Drug Therapy, Combination; Hemodynamics; Inflammation Mediators; Male; NF-kappa B; Nitric Oxide Synthase Type III; Norepinephrine; Propanolamines; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Reverse Transcriptase Polymerase Chain Reaction; Shock, Septic; Up-Regulation; Vasoconstrictor Agents | 2015 |
Gut and sublingual microvascular effect of esmolol during septic shock in a porcine model.
Topics: Animals; Disease Models, Animal; Female; Gastrointestinal Tract; Microcirculation; Oral Mucosal Absorption; Propanolamines; Random Allocation; Shock, Septic; Sublingual Gland; Swine | 2015 |
Combining Epinephrine and Esmolol Attenuates Excessive Autophagy and Mitophagy in Rat Cardiomyocytes After Cardiac Arrest.
Topics: Adrenergic Agonists; Adrenergic beta-1 Receptor Antagonists; Animals; Autophagy; Biomarkers; Cytoprotection; Disease Models, Animal; Drug Therapy, Combination; Energy Metabolism; Epinephrine; Heart Arrest; Injections, Intravenous; Male; Mitophagy; Myocytes, Cardiac; Propanolamines; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Time Factors | 2015 |
Acute myocardial ischemia up-regulates substance P in the retina of rats.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Disease Models, Animal; Male; Myocardial Ischemia; Phentolamine; Propanolamines; Protein Precursors; Rats; Rats, Sprague-Dawley; Retina; Substance P; Tachykinins; Time Factors; Up-Regulation | 2008 |
Effect of tidal volume, sampling duration, and cardiac contractility on pulse pressure and stroke volume variation during positive-pressure ventilation.
Topics: Animals; Blood Pressure; Disease Models, Animal; Dobutamine; Dogs; Multivariate Analysis; Myocardial Contraction; Positive-Pressure Respiration; Probability; Propanolamines; Respiratory Insufficiency; Sensitivity and Specificity; Stroke Volume; Tidal Volume; Time Factors | 2008 |
Autonomic mechanism for initiation of rapid firing from atria and pulmonary veins: evidence by ablation of ganglionated plexi.
Topics: Adrenergic beta-Antagonists; Animals; Atrial Fibrillation; Atropine; Autonomic Denervation; Cardiac Pacing, Artificial; Catheter Ablation; Disease Models, Animal; Dogs; Electrophysiologic Techniques, Cardiac; Ganglia, Autonomic; Heart Atria; Injections, Intravenous; Muscarinic Antagonists; Propanolamines; Pulmonary Veins | 2009 |
Effect and mechanism of esmolol given during cardiopulmonary resuscitation in a porcine ventricular fibrillation model.
Topics: Adrenergic beta-Antagonists; Animals; Blotting, Western; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiopulmonary Resuscitation; Disease Models, Animal; Electrocardiography; Heart Ventricles; Male; Phosphorylation; Phosphotransferases; Propanolamines; Ryanodine Receptor Calcium Release Channel; Treatment Outcome; Ventricular Fibrillation; Ventricular Function | 2009 |
Post-treatment with selective β1 adrenoceptor antagonists provides neuroprotection against transient focal ischemia in rats.
Topics: Adrenergic beta-Antagonists; Animals; Brain Infarction; Brain Ischemia; Disease Models, Animal; Male; Morpholines; Nerve Degeneration; Neuroprotective Agents; Propanolamines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-1; Treatment Outcome; Urea | 2010 |
Heart protection by combination therapy with esmolol and milrinone at late-ischemia and early reperfusion.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Apoptosis; Cardiotonic Agents; Cyclic AMP-Dependent Protein Kinases; Disease Models, Animal; In Situ Nick-End Labeling; Infusions, Intravenous; Milrinone; Myocardial Reperfusion Injury; Myocardium; Myocytes, Cardiac; Phosphodiesterase 3 Inhibitors; Propanolamines; Rats | 2011 |
Effects of esmolol on systemic and pulmonary hemodynamics and on oxygenation in pigs with hypodynamic endotoxin shock.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Disease Models, Animal; Female; Hemodynamics; Infusions, Intravenous; Lipopolysaccharides; Monitoring, Physiologic; Propanolamines; Prospective Studies; Shock, Septic; Swine | 2011 |
Infusion of the beta-adrenergic blocker esmolol attenuates myocardial dysfunction in septic rats.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Cardiomyopathies; Cardiotonic Agents; Cytokines; Disease Models, Animal; Hemodynamics; Infusions, Intravenous; Male; Myocardium; Oxygen Consumption; Propanolamines; Rats; Rats, Wistar; Sepsis | 2005 |
How to distinguish between ischemic and nonischemic postsystolic thickening: a strain rate imaging study.
Topics: Adrenergic beta-Antagonists; Animals; Aortic Valve; Aortic Valve Insufficiency; Blood Pressure; Cardiotonic Agents; Disease Models, Animal; Dobutamine; Drug Combinations; Echocardiography, Doppler, Color; Heart Rate; Humans; Infusions, Intravenous; Injections, Intravenous; Ischemia; Propanolamines; Stress, Physiological; Swine; Swine, Miniature; Theophylline; Vasodilator Agents; Ventricular Function, Left | 2006 |
Modeling ischemia-induced dyssynchronous myocardial contraction.
Topics: Animals; Blood Pressure; Disease Models, Animal; Dobutamine; Dogs; Electrocardiography; Heart Rate; Myocardial Contraction; Myocardial Ischemia; Propanolamines; Ventricular Dysfunction, Left | 2006 |
Association of increased myocardial contractility and elevated end-diastolic wall tension with short-term myocardial ischemia: a pressure-volume analysis.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Blood Gas Analysis; Blood Pressure; Blood Volume; Diastole; Disease Models, Animal; Dobutamine; Heart Rate; Lactic Acid; Myocardial Contraction; Myocardial Ischemia; Propanolamines; Stimulation, Chemical; Swine; Swine, Miniature; Time Factors | 2007 |
Beta-adrenergic receptor antagonism preserves myocardial function after brain death in a porcine model.
Topics: Adrenergic beta-Antagonists; Animals; Brain Death; Disease Models, Animal; Heart Rate; Myocardial Contraction; Organ Preservation; Probability; Propanolamines; Random Allocation; Receptors, Adrenergic, beta; Sensitivity and Specificity; Swine; Time Factors; Ventricular Function, Left | 2007 |
Administration of milrinone before ischemia, in the presence of beta-blockade, to treat metabolic impairment and myocardial stunning in pigs.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Cardiac Output; Cardiotonic Agents; Coronary Stenosis; Disease Models, Animal; Heart Rate; Lactic Acid; Milrinone; Myocardial Reperfusion; Myocardial Stunning; Propanolamines; Random Allocation; Swine; Time Factors; Vascular Resistance; Ventricular Dysfunction, Left | 2008 |
Acute beta-blockade prevents myocardial beta-adrenergic receptor desensitization and preserves early ventricular function after brain death.
Topics: Adrenergic beta-Antagonists; Animals; Brain Death; Disease Models, Animal; Heart; Myocardium; Propanolamines; Receptors, Adrenergic, beta; Swine; Ventricular Function | 2008 |
Anti-arrhythmic efficacy of beta-adrenergic blockade during acute ischemia in myocardium with scar.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Blood Pressure; Disease Models, Animal; Dogs; Heart Rate; Male; Myocardial Infarction; Myocardial Ischemia; Propanolamines; Ventricular Fibrillation | 1994 |
Effect of beta-blockade on dobutamine stress echocardiography.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Coronary Disease; Disease Models, Animal; Dobutamine; Dogs; Echocardiography; Hemodynamics; Infusions, Intravenous; Propanolamines | 1996 |
Myocardial protection with high-dose beta-blockade in acute myocardial ischemia.
Topics: Acute Disease; Adrenergic beta-Antagonists; Animals; Biopsy; Cardiac Output, Low; Cardiopulmonary Bypass; Coronary Artery Bypass; Coronary Circulation; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Edema; Female; Heart Arrest, Induced; Male; Myocardial Ischemia; Myocardium; Postoperative Complications; Propanolamines; Ventricular Function, Left | 2000 |
The class III antiarrhythmic effect of sotalol exerts a reverse use-dependent positive inotropic effect in the intact canine heart.
Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Disease Models, Animal; Dogs; Electrophysiology; Female; Male; Myocardial Contraction; Propanolamines; Sotalol | 2000 |
Dependence of early cerebral reperfusion and long-term outcome on resuscitation efficiency after cardiac arrest in rats.
Topics: Animals; Blood Flow Velocity; Blood Pressure; Brain; Carbon Dioxide; Cardiopulmonary Resuscitation; Cerebrovascular Circulation; Disease Models, Animal; Heart Arrest; Heart Rate; Magnetic Resonance Imaging; Male; Propanolamines; Rats; Rats, Sprague-Dawley; Survival Rate; Time Factors; Treatment Outcome | 2002 |
Endovascular stimulation within the left pulmonary artery to induce slowing of heart rate and paroxysmal atrial fibrillation.
Topics: Acute Disease; Adrenergic beta-Antagonists; Animals; Atrial Fibrillation; Atropine; Autonomic Nervous System; Disease Models, Animal; Dogs; Electric Stimulation; Electrocardiography; Endothelium, Vascular; Heart Rate; Muscarinic Antagonists; Propanolamines; Propranolol; Pulmonary Artery | 2002 |
Esmolol decreases the adverse effects of acute coronary artery occlusion on myocardial metabolism and regional myocardial blood flow in dogs.
Topics: Analysis of Variance; Animals; Collateral Circulation; Coronary Circulation; Coronary Disease; Disease Models, Animal; Dogs; Female; Hemodynamics; Lactates; Male; Myocardium; Propanolamines; Random Allocation; Receptors, Adrenergic, beta | 1988 |